Cabozantinib in Combination With Cetuximab in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Cancer

Clinical trial NCT03667482 · COMPLETED

Trial details

NCT number: NCT03667482
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Head and Neck Squamous Cell Cancer Recurrent Head and Neck Squamous Cell Cancer Metastatic Head and Neck Squamous Cell Cancer

Start date: 2018-09-07
Primary completion: 2024-07-17
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.